Opus Point Partners Management, LLC - MERRIMACK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
Opus Point Partners Management, LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2016$753,000
-22.2%
90,000
-26.5%
0.58%
-8.9%
Q4 2015$968,000
+83.3%
122,500
+97.6%
0.64%
+118.8%
Q3 2015$528,000
-40.7%
62,009
-13.9%
0.29%
-58.6%
Q2 2015$890,000
+4.1%
72,0090.0%0.70%
-1.7%
Q1 2015$855,000
+5.0%
72,0090.0%0.72%
-10.9%
Q4 2014$814,00072,0090.80%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 775,571$2,389,0000.93%
KEMPNER CAPITAL MANAGEMENT INC. 148,985$459,0000.31%
Yakira Capital Management, Inc. 248,420$765,0000.27%
GARRISON BRADFORD & ASSOCIATES INC 87,700$270,0000.24%
Cannell & Co. 1,212,478$3,734,0000.13%
LeJeune Puetz Investment Counsel LLC 3,976$180,0000.13%
ALPINE WOODS CAPITAL INVESTORS, LLC 726,000$2,236,0000.12%
Virtus ETF Advisers LLC 198,735$612,0000.11%
STONERIDGE INVESTMENT PARTNERS LLC 199,227$614,0000.08%
Birchview Capital, LP 44,000$136,0000.08%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders